GLPwatch
Papers (10386)
Page 135 of 174, ranked by citation count.
- Design and Biosynthesis of Ornithine 8-Containing Semaglutide Variants with a Click Chemistry-Modifiable Position 26.
- Acute Kidney and Liver Injury Associated With Low-Dose Liraglutide in an Obese Adolescent Patient.
- Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors.
- Choosing among the incretin agents and why it matters.
- Hedgehog interacting protein as a circulating biomarker in women with obesity: a cross-sectional study and intervention studies.
- Enhancing GLP-1 expression via IVT mRNA and fusion protein technology for diabetes therapy.
- Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes.
- Response to "Liraglutide effect on epicardial fat: Missing the forest for the trees".
- Oral semaglutide (Rybelsus) for type 2 diabetes.
- Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment.
- The effect of Semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance.
- [Successful treatment with liraglutide in type 1 diabetes and MODY].
- Effects of Exenatide plus Metformin versus Metformin alone on insulin resistance in women with Polycystic Ovary Syndrome: A systematic review and meta-analysis.
- Recognizing overweight and obesity as chronic diseases and acknowledging root causes.
- Is liraglutide safe and effective in the elderly obese patients?: A single center experience.
- Glucagon-like peptide-1 receptor PET/CT with <sup>68</sup>Ga-exendin-4 for localizing insulinoma: a real-world, single-center study.
- Chronic Stress Alters Hippocampal Renin-Angiotensin-Aldosterone System Component Expression in an Aged Rat Model of Wolfram Syndrome.
- Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice.
- Real-world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases.
- Putting More Weight on Obesity Trials in Heart Failure.
- ARD-101, a gut-restricted TAS2R agonist, reduces hunger in adults and promotes weight loss in DIO mice with DPP-4 inhibition.
- GLP1 receptor agonism alters growth and therapeutic response in prostate cancer.
- Aliskiren, exendin-4, and insulin: their impact on endothelin receptor subtype(s) regulation/binding in type 1 diabetic rat hearts.
- Effect of Semaglutide on C-peptide levels in patients with type 2 diabetes.
- Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor.
- Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation.
- A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules.
- Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.
- Effect of pH, buffers, molarity, and temperature on solution state degradation of semaglutide using LC-HRMS: A preformulation protocol for peptide drug delivery.
- Improving beta-cell secretory function and glycaemia in young-onset type 2 diabetes: A pilot, 12-month, randomized trial of a novel, continuous glucose monitor-guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide.
- Efficacy and safety of semaglutide in non-diabetic adults with overweight or obesity: A meta-analysis of randomized controlled trials.
- Evolving directions in obesity management.
- Liraglutide therapy in obese people with type 2 diabetes - experience of a weight management centre.
- Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide.
- Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction.
- The impact of oral semaglutide on glycemic control and weight reduction: a database analysis of dosing effects in Japanese individuals with type 2 diabetes.
- RYGB induces vagal sensory neuropathy characterized by altered Glp1r expression and enhanced exendin-4 responsiveness in male mice.
- [Effect of liraglutide on glucagon secretion in obese type 2 diabetic patients].
- Mexican population sub-analysis of the lixilan clinical program with the fixed ratio combination of insulin glargine and lixisenatide (iGlarLixi).
- PIONEER REAL Saudi Arabia: A multicentre, prospective, real-world study of once-daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia.
- Safety Choice Drivers of the Coming Treatment Options for Non-Cirrhotic Metabolic Steatohepatitis.
- Treating with liraglutide an obese patient with type 2 diabetes mellitus and hereditary hemochromatosis.
- The impact of GLP-1 agonists on sleep disorders: spotlight on sleep apnea.
- Clinical Potential of GIP in Type 2 Diabetes and Obesity.
- Mixing Pens and the Future of Diabetes Drugs.
- The Cardiovascular Outcomes Between Liraglutide and Dulaglutide Among Different Chronic Kidney Disease Stages in Patients With Type 2 Diabetes.
- Analysis on difference in gastrointestinal hormone levels of patients with the history of diabetes and concurrent nephropathy and study on the role of liraglutide.
- Incretin-induced changes in the transcriptome of skeletal muscles of fa/fa Zucker rat (ZFR) with obesity, without diabetes.
- Therapy: Liraglutide - preventing or postponing T2DM diagnosis?
- Activation of GLP-1R ameliorates microglial pyroptosis after spinal cord injury by restoring FANCC expression.
- Glucagon-Like Peptide-1 Receptor Agonists Combined With Personalized Digital Health Care for the Treatment of Metabolic Syndrome in Adults With Obesity: Retrospective Observational Study.
- Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy.
- Basal insulin intensification in type 2 diabetes: a key role for GLP-1 receptor agonists.
- [Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease].
- Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.
- Characterizing the D-Amino Acid Position in Peptide Epimers by Using Higher-Energy Collisional Dissociation Tandem Mass Spectrometry: A Case Study of Liraglutide.
- Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation-specific risk.
- Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients.
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events.
- Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides.